PeptiDream gets milestone as BMS selects pre-IND candidate

PeptiDream Inc. (Tokyo:4587) gained Y1,320 (11%) to Y13,300 on Thursday on news it received an undisclosed milestone payment from Bristol-Myers Squibb Co. (NYSE:BMY) after the pharma designated a compound covered by the companies' partnership as a candidate for exploratory clinical development. PeptiDream CSO Patrick Reid declined to disclose details about the compound, its target or indications. ...